The Michigan Long-Term PBB Study was established following exposure to polybrominated biphenyls (PBBs) in the early 1970s. Serum samples from cohort members were analyzed for PBB during 1976-1993. More than 20 years following this industrial incident, some participants still had measurable serum PBB concentration levels. Thus, there is continuing interest in understanding the elimination of PBB from the body. In the present study, we estimated serum PBB decay and investigated the effects of covariates on serum PBB decay rates among 406 female cohort members. We developed a decay model using a general linear mixed model, which attributes unique intercept and slope estimates for each individual while borrowing information across individuals for predicting these quantities. Age at exposure and body mass index (BMI) at the initial measurement were time-independent covariates. Time since exposure, smoking history, pregnancy status, and breast-feeding status were time-dependent covariates. Higher BMI was associated with a slower decay rate; smokers had a faster decay rate than nonsmokers; and increasing age at exposure was marginally associated with a slower decay rate. Our results suggest a faster serum PBB decay rate for women who breast-fed during the interval between serum PBB measurements. To evaluate the predictive performance of our modeling approach, we compared the results from this model with those from a previously developed ordinary least squares (OLS) two-stage decay model. The mixed-effects decay model predicted the observed serum PBB concentration levels significantly better than the OLS two-stage decay model (mixed-effects model, r ¼ 0.93; OLS two-stage model, r ¼ 0.86; Po0.0001).
Introduction
Polybrominated biphenyls (PBBs) are manufactured chemicals added as flame retardants to electrical devices, plastics, and various textiles. PBBs belong to the largest class of flame retardants used commercially (Birnbaum and Staskal, 2004) . Brominated flame retardants continue to raise health concerns because of their environmental persistence and potential toxic effects (Birnbaum and Staskal, 2004; Sjodin et al., 2004) . A widespread contamination with PBBs occurred in Michigan during 1973 Michigan during -1974 when FireMaster FF-1 (a mixture of PBBs), instead of NutriMaster (a magnesium oxide feed supplement), was accidentally mixed with animal feed. Some livestock developed symptoms of acute toxicity, resulting in their slaughter (Carter, 1976) . In addition, residents on Michigan farms and neighboring communities were exposed to PBBs by consuming meat, milk, and other food products from contaminated animals (Fries, 1985) . As a result of this incident, the Michigan Department of Public (now Community) Health, in collaboration with the US Public Health Service, established a registry of individuals exposed to the contaminated food products to assess potential short-and long-term health effects (Landrigan et al., 1979) . Additional information on the Michigan PBB incident and the Michigan Long-Term PBB Study is published elsewhere (Humphrey and Hayner, 1976; Kay, 1977; Landrigan et al., 1979; Fries, 1985) .
PBBs are stable, persistent halogenated organic pollutants with extremely long half-lives. (Eyster et al., 1983; Miceli et al., 1985) . Animal studies have suggested thyroid, hepatic, reproductive, cancer, and developmental effects after high levels of oral exposure to PBB (Damstra et al., 1982; ATSDR, 2004) . In exposed individuals, PBBs are partially metabolized and excreted in feces or stored in fatty tissues where they persist for many years (ATSDR, 2004) . In addition, there is some evidence that PBBs have endocrinedisrupting properties in humans (Blanck et al., 2000b; Davis et al., 2005) . PBB exposure is of special concern to the fetus and neonate because it can cross the placenta and is concentrated in breast milk (Wolff et al., 1982; Eyster et al., 1983; Jacobson et al., 1989; Anderson and Wolff, 2000) . The highest PBB concentrations in the body are found in adipose tissue, but PBBs can be detected at lower concentrations in serum and other tissues (Eyster et al., 1983; Miceli et al., 1985) .
Although the contamination period ended in the mid 1970s and PBB production ceased in the United States in 1977, participants in the cohort continued to have measurable serum PBB concentration levels more than 20 years later. Thus, there is continuing interest in understanding the elimination of PBB from the body. When multiple exposure measurements are available, a common approach used to explore the relationship between exposure outcomes and covariates is through the development of a statistical model. In particular, a decay model provides a means for predicting exposure levels and describing changes in exposure levels over time. For the PBB study, the purpose of developing a decay model was two-fold. First, the decay model presented an opportunity to explore the relationship between various covariates and their influence on serum PBB decay (Blanck et al., 2000a) . Second, the model provided an efficient way for estimating serum PBB concentration levels for use in subsequent studies that have explored various health outcomes among women in the cohort (Blanck et al., 2000b (Blanck et al., , 2002 Thomas et al., 2001; Davis et al., 2005) .
The one-compartment, first-order, exponential decay model developed by Blanck et al. (2000a) used an ordinary least squares (OLS) approach. With this OLS method, individual slopes for each woman's log-transformed serum PBB measurements were calculated. These slopes were then used as the outcome variable in a multiple linear regression model that included time-independent covariates for age, body mass index (BMI), smoking, parity, and breast-feeding status. Although this two-stage modeling approach provides a simplistic modeling structure, it ignores several important aspects of the data and has several methodological deficiencies. When data points are limited, as in the Michigan LongTerm PBB Study, where many women have only two or three serum PBB measurements, the slope estimates computed from the OLS two-stage modeling approach are rough and vary in precision across women according to the number of measurements. Further, the model does not have the advantage of flexibly handling time-dependent covariates, such as pregnancy status or breast-feeding status that would naturally change over the course of a woman's life.
The approach we suggest in this paper addresses these limitations by developing a more sophisticated decay model using general linear mixed model procedures (Laird and Ware, 1982; Verbeke and Molenberghs, 2000) . The mixed model approach is more powerful than the previous approach because it accounts for differences in the number of observations across women and accounts for withinwomen correlations. In addition, this modeling approach can appropriately adjust for time-dependent covariates, such as breast-feeding status. When the between-subject variability is large in comparison to the within-subject variability, the mixed model borrows strength across all individuals to provide more reliable and precise estimates of individual decay rates (Verbeke and Molenberghs, 2000) .
One objective of this article is to demonstrate that the linear mixed model approach can be used to develop a decay model from longitudinal data in the presence of both timeindependent and time-dependent covariates. We developed this model by using serum PBB measurements collected during 1976-1993 from women participants of the Michigan Long-Term PBB Study. Further, we used the decay model to determine and analyze the impact of important predictors of serum PBB decay. We also evaluated the predictive performance of our modeling approach and compared the results from this model with those from the Blanck et al. (2000a) decay model. We used the latest serum PBB measurements to compare the observed values with the predicted values based on the two developed decay models.
Methods

Study population
Since the initial enrollment period (1976) (1977) (1978) , the Michigan Department of Community Health (MDCH) has periodically contacted cohort members to obtain additional serum samples to measure PBB concentration levels, to obtain updated information on health outcomes, and to enroll children born to exposed mothers. The Michigan Female Health Study (MFHS), which originated in 1997, recruited women from the Michigan Long-Term PBB Study to address possible links between PBB exposure and reproductive and endocrine outcomes. Investigators designed a structured telephone interview to obtain information on demographics, lifestyle, reproduction, and breast-feeding from women in the cohort who were at least 18 years of age.
In the current study of serum PBB decay, we included females who were born before the contamination incident (July 1973) if they had at least two serum PBB measurements, an initial serum PBB measurement of Z2 parts per billion (p.p.b.) and if the time between any two consecutive measurements was at least 6 months apart (n ¼ 406; Figure 1 ). We required an initial serum PBB measurement of at least 2 ppb to ensure that their levels were above the limit of detection of 1 ppb. We excluded measurements collected before age 16 because childhood growth could potentially affect the compartment mobility and thus the equilibrium of serum PBB concentration levels (Wolff and Schecter, 1991) . We also excluded measurements taken during pregnancy or during any period of breast-feeding because of the potential mobilization of PBB into the bloodstream during these times (Eyster et al., 1983; Kreuzer et al., 1997) .
Serum PBB samples
Serum PBB samples have been collected over 17 years (from 1976 to 1993) for 1845 women enrolled in the Michigan Long-Term PBB Study. Sera collected during [1976] [1977] [1978] [1979] [1980] [1981] [1982] [1983] [1984] [1985] [1986] [1987] [1988] were analyzed by the MDCH Bureau of Laboratories by using packed-column electron capture gas chromatography. The calibration standard used for the packed-column method was FireMaster BP-6 (standard during January -July 1976). After that time, FireMaster FF-1, a mixture of BP-6 with an added 2% anti-caking agent, was used. The main congener in FireMaster FF-1 is 2,2 0 ,4,4 0 ,5,5 0 -hexabromobiphenyl, also known as PBB-153. In brief, the serum samples were denatured, extracted with 1:1 petroleum ether-ethyl or 1:1 hexane-ether and chromatographed through either a Florisil or Florisil and silica gel column. Quantitation was performed by comparing the chromatography peak size with the peak size of a control sample containing a known quantity of FireMaster FF-1.
PBB serum samples collected during 1976-1978 were analyzed for PBB alone (single extraction procedure) (Burse et al., 1980) . Later samples (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) were analyzed with a modified combined method designed to identify and quantify either PBB and polychlorinated biphenyl (PCB) (Needham et al., 1981) or PBB, PCB, and several pesticide concentrations (Price et al., 1986; Brock et al., 1996) . The reproducibility of samples analyzed with the combined method was evaluated by comparing samples spiked with known quantities of PBB. The coefficient of variation ranged from 7.1% to 14% (Needham et al., 1981) . Comparison among these PBB detection methods revealed no systematic differences (Kreiss et al., 1982) . In an interlaboratory study, Burse et al. (1980) found very high agreement between 446 duplicate PBB samples analyzed with packed-column gas chromatography in two laboratories (MDCH and CDC) (r ¼ 0.998).
PBB serum samples collected during 1991-1993 were analyzed using capillary gas chromatography, with electron capture detection (Najam et al., 1999; Humphrey et al., 2000) . This method allowed the separation of individual congeners of PBB and PCB, as well as determination of specific pesticide concentrations. For PBB, quantitation was achieved using an automated integration program followed by comparison of peak areas and retention times with that of a known standard, PBB-153. Quality control measures included analyzing duplicate samples and a set of spiked control samples. To assess method quality, a known quantity of PBB-155 was added to each sample. Concentration levels outside of the 95% confidence level for the spiked material were re-analyzed. This resulted in 1% of the samples being re-analyzed.
The MDCH Bureau of Laboratories described the relationship among the three different standards used during the PBB study (BP-6, FF-1, and PBB-153). The laboratory determined that for samples analyzed with BP-6 as the standard, 1 ng/g BP-6 ¼ 0.53 ng/g PBB-153 and for samples analyzed with FF-1 as the standard, 1 ng/g FF-1 ¼ 0.60 ng/g PBB-153. Thus, applying a multiplicative factor of 0.53 to samples analyzed with BP-6 converts them to units of PBB-153. Likewise, FF-1 sample concentrations multiplied by 0.60 yields concentrations in units of PBB-153. The minimum quantifiable level for serum PBB concentrations was 1.0 ppb (ppb ¼ ng/g). PBB concentration levels below this limit were set to 0.5 ppb, half of the unadjusted limit of detection (Hornung and Reed, 1990) . All samples were collected from non-fasting subjects, and PBB concentration levels were not lipid adjusted.
Data description
For this study, we used retrospective data from the PBB registry, which included information from the initial enrollment questionnaires in 1976-1978 as well as follow-up questionnaires that have been completed in subsequent years; the MFHS telephone interview (1997) (1998) ; and the exposure database, which contains all available serum PBB measurements. Height and weight data were obtained from the initial enrollment questionnaire, unless the participant was younger than 16 years of age at enrollment and the initial PBB measurement was taken after the enrollment period. For these individuals (n ¼ 6), weight data were obtained from a follow-up questionnaire and height data were obtained from the MFHS telephone interview. BMI was calculated as weight (kg)/(height (m)) 2 . Smoking habits (ever smoked, age when first started smoking, age when stopped smoking), pregnancy history (pregnancy dates and outcomes), and breast-feeding history (duration of breast-feeding in months and months when breast-feeding stopped) were obtained from the MFHS telephone interview. Duration of breast-feeding was calculated as the number of months the child was breast-fed exclusively plus half the number of months the child was breast-fed with supplementation (Wickizer and Brilliant, 1981; Rogan et al., 1987) . For women who did not participate in the telephone interview (n ¼ 41), information on smoking status was obtained from the enrollment and follow-up questionnaires, and pregnancy and breast-feeding information was obtained from infant enrollment questionnaires.
The longitudinal data set was arranged vertically with one observation per serum PBB measurement, yielding 2-7 measurements per woman. The number of measurements varied because some women have been included in multiple studies, especially those women with higher initial PBB concentration levels (Z10 p.p.b.). The outcome variable, serum PBB concentration levels measured in ppb, was continuous. The time-independent covariates were age at exposure (treated as a continuous variable or in categories of o18, 18-50, and 450) and BMI at the initial measurement (treated as a continuous variable or in categories of o23 kg/m 2 and Z23 kg/m 2 ). For the time-varying covariates, time since exposure was defined as the time elapsed from July 1973 to the collection date of the serum PBB measurement, in years. Smoking, pregnancy (ending in a live birth or stillbirth), and breast-feeding status were dichotomous variables (''yes'' or ''no'') depending on whether they occurred during the interval between two consecutive measurements. The completed data set contained 1142 serum PBB measurements from 406 women.
Statistical methods
The decay model proposed in this article utilizes a general linear mixed model for the log-transformed serum PBB measurements. For the PBB data, we let ðY i1 ; Y i2 ; . . . ; Y in i Þ represent the n i repeated serum PBB measurements for the ith individual. Time since exposure is represented as the ðt i1 ; t i2 ; . . . ; t ini Þ for n i repeated measurements for the ith individual. In the linear mixed model it is assumed that the repeated measurements for each individual follow a linear regression model where some of the regression parameters are population specific and some parameters are subject specific (Verbeke and Molenberghs, 2000) . Thus, we write
where the parameter a measures the overall population average serum PBB concentration level at the initial measurement. The random effect a i reflects how much the subject-specific intercept deviates from the overall average intercept, so that (a þ a i ) denotes the true intercept. Similarly, b represents the overall average serum PBB decay rate and b i represents the deviation in the decay rate for the ith subject. Hence, the model specifies a decay rate of (b þ b i ) for the ith subject. The predictive model for the ith subject becomes
In Eq.
(1), the random effects a i and b i are assumed to follow a normal distribution and are predicted with the empirical Bayesian approach (Littel et al., 1996; Verbeke and Molenberghs, 2000) , yielding the estimates â i and bˆi. Moreover, the estimatesâ andb parameters are based on a restricted maximum likelihood estimation. Equations (1) and (2) can be extended to include covariates. For example, a decay model with a smoking effect can become
For a nonsmoker, a person's log-scale intercept and slope remains (a þ a i ) and (b þ b i ) in this case, respectively. However, if the same person smokes at a later time, the log-scale intercept and slope will change by a 1 and b 1 to become (a þ a 1 þ a i ) and (b þ b 1 þ b i ), respectively. Exponentiating Eq. (3) for the untransformed serum PBB measurements gives the equation
The decay rate can be obtained directly from Eq. (4), where
and a negative l would indicate a decline in serum PBB concentration levels over time.
Building the decay model
Information on all 406 women was included during model building. First, we performed an exploratory analysis that consisted of examining missing data, assessing the normality of the response variable, and graphically observing individual profiles. We excluded measurements during model fitting that were missing information on any covariate. Eight PBB measurements were excluded because of missing covariate information. To investigate the data quality and to check for skewness and outliers, we created histograms and scatter plots of the serum PBB concentration levels. Individual profile graphs assisted in identifying time trends and outliers that existed in the data. We generated correlation matrices to check for potential associations among covariates and to assess the variance and covariance assumptions for the exposure variable. The preliminary model included intercepts and slopes for age, BMI, smoking, and pregnancy-by-breast-feeding. The continuous covariates, age and BMI, were centered around their mean. The pregnancy-by-breast-feeding covariate was a combined three-level term representing no pregnancy, pregnancy with no breast-feeding, or pregnancy and breastfeeding during the interval of two consecutive serum PBB measurements. To assess whether each covariate affected the rate of decay, we included interactions between time and the specific covariate of interest. We also allowed for BMIby-pregnancy, BMI-by-age, age-by-pregnancy, and age-bysmoking interactions. Models with a quadratic and cubic time effect were evaluated; however, a linear time trend was determined to be sufficient. We used the preliminary model to test random-effects covariance structures. It was appropriate to include a random slope in addition to a random intercept in the decay model. Akaike information criteria (Akaike, 1974) compared models fit with various residual covariance structures. The unstructured and compound symmetric models presented convergence problems or were inappropriate for the data. We selected the spatial power structure rather than the simple structure because it improved the fit of the model and properly adjusted for the unequal spacing among the serum PBB measurements (Littel et al., 1996) . We used a backward elimination approach to obtain a reduced model and retained all covariates that were significant at the a ¼ 10% level. Separate intercepts for each covariate of interest were not retained in the reduced model because variations in individuals at baseline were assumed to be independent of exposure and were accounted for by the random effects only. We assessed the fit of the models at the 5% significance level. All analyses were performed in SAS v9.1, and models were fit with the Mixed procedure (SAS Institute, 2004) .
Validating the decay model
We validated the mixed-effects decay model by comparing predicted serum PBB concentration levels derived from two newly developed models using a subset of the available data. Women were included in this substudy if they had a minimum of three measurements, of which one was collected during 1991-1993 (n ¼ 151 women). After excluding the PBB measurements collected in 1991-1993, we modeled the remaining 898 measurements from 1976 to 1988. The first model was developed with the mixed-effects modeling approach described in the present analysis. The second model was developed with the same measurements using the OLS two-stage modeling approach described by Blanck et al. (2000a) . Predicted serum PBB concentrations from these two models, the mixed-effects model and the OLS two-stage model were compared to the observed serum PBB concentrations collected during 1991-1993. Predicted serum PBB values were calculated at time t i *, defined as the years from exposure to the date on which the 1991-1993 serum PBB sample was collected for the ith subject. We evaluated mean squared errors (MSE) between the observed and predicted values. The Pearson's correlation coefficients were also derived for the observed and predicted serum PBB values from the two models. We calculated concordance correlation coefficients to assess the linear relationship as well as departures from the 45-degree line (Lin, 1989) . Finally, to compare the performance of the Pearson's correlation coefficients, we performed Steiger's Z-test for correlated correlations within a population (Steiger, 1980) .
Results
Tables 1 and 2 summarize demographic characteristics and exposure details for the 406 participants. The average age at the time of exposure was 28 years and nearly 30% of the women were 2-17 years of age at exposure. Between the initial and the last PBB measurements (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) , a majority of the women reported being nonsmokers (77%) and most were nulliparous (71%). Only 16% of the women reported breast-feeding at some time between the years of their PBB measurements (Table 1 ). The initial serum PBB measurements were obtained between 1976 and 1987, and yielded a median exposure level of 2.4 p.p.b. (Table 2) . Participants had serum PBB measurements taken over an average of 9 years, and most of the women had a total of two (45%) or three (37%) samples collected. Participants had serum PBB measurements taken over an average of 9 years, and most of the women had a total of two (45%) or three (37%) samples collected. Only 5% of the second and subsequent PBB measurements were below the limit of detection (38 of 736 samples). Fifty-one percent of the women had a serum PBB measurement collected in 1991-1993. Of these women (n ¼ 207), 87% (n ¼ 180) still had detectable serum PBB concentration levels during that time.
Individual profiles of the log-transformed serum PBB concentration levels for a random sample of women (n ¼ 50) in the study group are shown in Figure 2 . The time trends reveal slight reductions in PBB concentration levels over time. Further, the figure illustrates greater between-subject variability than within-subject variability. The range of the initial serum PBB measurements for these women was vast (1.2-342.0 ppb), justifying the need for a random intercept in the decay model.
The final mixed-effects model is shown in Table 3 . Nonsignificant interactions between covariates were removed from the model. We retained an overall intercept and an overall slope, as well as random intercepts and random slopes for each individual. The estimates for remaining covariates in the model represent their effects on the rate of serum PBB decay. The model indicates a significant decline in log (PBB) values over time. For a woman 28 years of age at exposure, with an initial BMI of 24 kg/m 2 and no history of smoking or pregnancies between PBB measurements, the average decrease (decay rate) is À0.011 log (PBB) ppb per year (Table 3) . Increasing age at exposure (above the average age) was indicative of a slower decay rate, but this was marginally significant. An increase in the rate of change of 0.001 log (PBB) ppb per year was associated with each kg/m 2 above the mean BMI (Table 3) . Women who smoked between measurements had a slightly faster estimated decay rate, by À0.008 log (PBB) ppb per year. The pregnancy-bybreast-feeding effect was statistically significant; however, only 116 women were parous and only 65 of these women breast-fed. On average, the decay rate was slowest for a woman who was pregnant and did not breast-feed. Finally, the decay rate was significantly faster for a woman who breast-fed between measurements than for a woman who was pregnant but did not breast-feed (P ¼ 0.0095, Table 3 ).
We examined variations of the final mixed-effects model that included the deletion of outliers and alternate forms of covariates. Removing five women who had outlying serum PBB measurements altered the estimates slightly, but the significance and interpretations of the covariates remained unchanged. A categorical age-at-exposure variable (o18 years, 18-50 years, and 450 years) in the model was not significantly associated with the estimated serum PBB decay rate as compared to the model with age at exposure as a continuous variable (P ¼ 0.742). A dichotomized BMI variable (o23 kg/m 2 and Z23 kg/m 2 ) remained significant, suggesting that women with a BMI above the median experienced a slower decay in serum PBB concentration levels (P ¼ 0.028).
We performed two sensitivity analyses using the final mixed-effects model and all available serum PBB measurements to address the fact that individuals had various numbers of measurements and that those with higher exposures were more likely to have more measurements. In the first analysis, the decay model was weighted based on the number of measurements per woman. Inferences based on this weighted mixed-effects model were similar to those based on the unweighted mixed-effects model (data not shown). In the second analysis, the decay model was stratified by exposure levels. The low-exposure group included women with an initial PBB concentration level of o10 ppb (n ¼ 353) and the high-exposure group had an initial PBB concentration level of Z10 ppb (n ¼ 53). We found results in the stratified mixed-effects model that were similar to those in our final mixed-effects model (data not shown). The overall rate of decay was faster among women in the high-exposure group than the low-exposure group. The BMI effect was to some extent stronger among women in the high-exposure group, whereas the smoking effect was more apparent in the women from the low-exposure group. The pregnancy-bybreast-feeding effect in the high-exposure group was not as strong as in the low-exposure group, possibly because of the small number of breast-feeders in this group (n ¼ 11) than in the low-exposure group (n ¼ 54).
Following the sensitivity analyses, we performed a validation study to assess the performance of our final mixed-effects model. We developed two additional decay models independent of the latest (1991) (1992) (1993) serum PBB measurements for a subset of the study group (n ¼ 151). The parameter estimates for the OLS two-stage model and the mixed-effects model using PBB measurements from 1976 to 1988 are shown in Table 4 . A comparison of the mixedeffects models in Tables 3 and 4 reveal similar parameter estimates and the direction of the effects are unchanged. Overall, the maximum observed serum PBB concentration level for the 1991-1993 measurements was 337 ppb. The maximum predicted serum PBB concentration level obtained using the mixed-effects model in the current study was 267 ppb, and that obtained using the OLS two-stage model was 755 ppb (Table 4) . The MSE, a measure of accuracy, was three times smaller in the mixed-effects model (MSE ¼ 0.325) than in the OLS two-stage model (MSE ¼ 1.199). Figure 3 shows side-by-side plots of the observed log-transformed serum PBB concentration levels against the predicted logtransformed serum PBB concentration levels from both models. The mixed-effects model outperformed the OLS two-stage model and appeared to have better predictive power. The points clustered more closely around the line using the mixed-effects model and outlying observations were minimized. In addition, the linear relationship between the observed and the predicted serum PBB concentration levels from our model was stronger than with the OLS two-stage model (mixed-effects model r ¼ 0.93; OLS two-stage model, r ¼ 0.86). Our model predicted the observed serum PBB concentration levels significantly better than the OLS twostage decay model (Z ¼ 5.92; Po0.0001). Likewise, the concordance correlation coefficient was higher using our model for predicting serum PBB concentration levels (mixedeffects model, r c ¼ 0.90; OLS two-stage model, r c ¼ 0.73).
Discussion
The mixed-effects model is a powerful statistical tool for analyzing longitudinal data. The model incorporates variations within and between individuals and adjusts for covariate differences between individuals. It provides subject-specific parameter estimates, which can aid researchers in generating a more predictive model. Further, this approach can flexibly incorporate time-dependent covariates. For example, we were able to adjust for a smoking, pregnancy, or breast-feeding episode during the interval between serum PBB measurements.
Further analysis included weighting the decay model by the number of serum PBB measurements to address the fact that women with more measurements appeared to have higher serum PBB concentration levels than other women in the cohort. The weighted model did not show meaningful changes in the parameter estimates obtained in the unweighted decay model. This is in agreement with Blanck et al. (2000a) and Rosen et al. (1995) who reported minimal changes when they weighted their models in a similar manner.
Our mixed-effects decay model has several limitations. Almost half of the study participants (45%) had only two serum PBB measurements. This limits the potential effects of the time-dependent covariates in the model. We did not consider continuous covariates for the number of pregnancies or breast-feeding duration because of the unequal spacing between the serum PBB measurements. Women whose measurements were farther apart could potentially have had a greater chance for either event to occur. We must also point out that generalization of the results from our decay model is limited to women within this cohort.
Another limitation is that we were unable to treat BMI as a time-varying covariate because height and weight were not captured regularly during the years of the cohort. However, to determine the impact of a change in BMI on PBB decay, we performed additional analyses restricted to women with a second BMI available (n ¼ 192). These women had a 1991-1993 serum PBB measurement and they reported their current weight in a survey completed around the same time, which was used to calculate this subsequent BMI. We created a time-varying three-level BMI variable defined as rÀ5% change in BMI (defined as weight loss, n ¼ 29), Z5% change in BMI (defined as weight gain, n ¼ 117), or no change in BMI (referent group: remaining women, n ¼ 46). The decay rate for the initial BMI was no longer significant in the decay model with only the 192 women (decay rate ¼ 0.0003 log (PBB) ppb per year, P ¼ 0.62). However, the change in BMI decay rate was statistically significant. The decay rate was 0.019 log (PBB) ppb per year for women who lost weight and À0.002 log (PBB) ppb per year for women who gained weight, indicating that the decay rate was significantly slower for women who experienced weight loss since the initial PBB measurement compared to women who either gained weight or had no change in weight since the initial PBB measurement (P ¼ 0.0002). This is biologically plausible that PBB, which is stored in body fat may be released into the bloodstream during phases of weight loss elevating serum PBB levels and altering decay rate estimates.
Although we could not examine the effect of a change in BMI in our entire sample, the PBB decay rate was modified among the small group of women who lost weight. The impact of not incorporating a time-varying BMI variable among these women appeared to be small when we compared their predicted PBB levels in the models with and without the change in BMI variable (data not shown). Additional longitudinal studies are needed to further understand the influence of weight change over time on the decay of halogenated organic compounds.
Laboratory analytical methods and the standards for the quantification of serum PBB measurements have changed over the years. As a result, we have adjusted for the differences in standards (BP-6, FF-1, and PBB-153) by using PBB conversion factors. Laboratory practices at the time did not include empirical observations of variability in these conversion factors. However, the abundance of the main congener (PBB-153) in FireMaster is estimated to range from 53.9% to 68% (Fries, 1985) . When we altered our conversion factors (0.53 and 0.60) by ±5% and refit the final mixed-effects model, the direction of the estimates remained consistent, and the effect of smoking was slightly attenuated. The estimate for smoking increased by 0.001 log (PBB) ppb and the P-value changed from 0.046 in our final model to at most 0.082. We attribute this change to the small number of smokers in our population. Regarding changes in laboratory analytic methods, we were not able to apply a specific adjustment for the change in methods from packed-column (used from 1976 to 1988) to the more efficient capillarycolumn method (used from 1991 to 1993), which may result in additional measurement error. However, since we included a covariate in the decay model for the year the sample was analyzed and the final mixed-effects model fit well, this aspect of measurement error was unlikely to affect our main conclusions.
We did not have serum PBB concentration levels that were lipid adjusted, which may introduce an additional source of within-subject variability. All the PBB samples in this study were collected from non-fasting subjects. Therefore, serum lipid concentrations may vary because of the last meal eaten, the timing of the meal and genetic factors of the subjects. However, the use of lipid-adjusted concentration levels in statistical models remains debatable. It has been suggested that lipid adjustment may introduce bias (Schisterman et al., 2005) .
Another potential limitation of our final mixed-effects model is its predictive performance when observed PBB levels are below or near the limit of detection. In the validation study, the observed and predicted PBB levels were highly correlated (r ¼ 0.93), but Figure 3 shows that our predicted PBB levels were systematically lower than the observed PBB levels, particularly at observed levels at or below the limit of detection. The Pearson's correlation coefficient does not reflect the reduced accuracy at lower values. Thus, we also considered an alternative measure that captures accuracy as well as precision. The concordance correlation coefficient using the predicted PBB levels from our decay model suggested a strong agreement with the observed values (r c ¼ 0.90), even with these systematic differences. Further, this agreement was stronger than the predicted PBB levels using the OLS two-stage model (r c ¼ 0.73).
Despite these limitations, certain noteworthy conclusions can be drawn from our analyses. Each year above the mean age at exposure was predictive of a slower decay, although this was of marginal significance. In another study involving women in the Michigan PBB cohort, Sweeney et al. (2001) found that age at exposure (10 years or younger) was a predictor of a decrease in serum PBB concentration levels over time. In addition, our model suggested a higher BMI at the initial measurement that was associated with slower decay. In body burden studies of tetrachlorodibenzo-pdioxin, increasing percent body fat has been associated with a slower decay (Flesch-Janys et al., 1996; Michalek et al., 1996) . Changes in body fat may influence redistribution of these chemicals in the body, resulting in longer half-lives.
We included time-dependent covariates in our mixedeffects model to measure the change in serum PBB decay during a smoking, pregnancy, or breast-feeding episode. Women who smoked between measurements had a significantly faster decay rate than nonsmokers. Flesch-Janys et al. (1996) found a similar result for various polychlorinated dibenzo-p-dioxins, attributing it to the influence of smoking on P 450 enzymes. To assess further the smoking effect, we re-coded smoking as never-smoker (n ¼ 313), light-smoker (o15 cigarettes a day, n ¼ 34) and heavy-smoker (Z15 cigarettes a day, n ¼ 59). The estimates, which were based on a small number of smokers, confirmed that heavy-smokers had a slightly faster decay rate than light-smokers, but the rates were not statistically different (light-smokers decay rate ¼ À0.003 log (PBB) ppb per year; heavy-smokers decay rate ¼ À0.011 log (PBB) ppb per year; P ¼ 0.31).
Although we had a small number of parous women in our sample, we found a faster decay rate for women who breastfed between measurements compared to women who were pregnant and did not breast-feed. This seems plausible, given that halogenated organic compounds such as PBB and PCB can be transferred from mother to infant during breastfeeding (Eyster et al., 1983; Jacobson et al., 1984 Jacobson et al., , 1989 Anderson and Wolff, 2000) . In contrast to our finding, when pregnancy and breast-feeding were treated time independently, Blanck et al. (2000a) found no association with breast-feeding and a marginally significant association between slower serum PBB decay and increasing parity. Sweeney et al. (2001) did not find parity to be a significant predictor of change in PBB concentration levels over time.
Conclusions
The proposed mixed-effects decay model describes the influence of specific factors on serum PBB decay. Furthermore, the decay model provides a means for directly extrapolating to obtain estimates of a woman's serum PBB levels at various times, for example, to estimate in utero exposure of offspring. The developed model showed a significant decline in serum PBB concentration levels for the Michigan women included in our study. We found initial BMI, smoking status, and breast-feeding status to be significant predictors of serum PBB decay rates. However, age at exposure was only marginally significant. Among women with a subsequent weight reported, we found that weight loss had a significant effect on serum PBB decay rates.
In the validation study, we demonstrated the strength of our model in several ways. The predicted serum PBB concentration levels that were obtained with our mixedeffects model had a distribution similar to that of the observed serum PBB levels, and when we assessed the relationship between the observed and predicted values, our model was clearly an enhancement over the OLS two-stage approach. The model developed in this paper can be used to predict subject-specific serum PBB levels at future time points. Further, the use of the linear mixed-effects approach for modeling decay is a valuable tool that can be applied to other exposure studies where identifying factors that are predictive of decay or predicting exposure levels is of interest. 
